Evidence map›Paper›PMID 30486513›Full record

ArticleMolecules (Basel, Switzerland)2018

Cloning, Characterization and Anion Inhibition Studies of a β-Carbonic Anhydrase from the Pathogenic Protozoan

Susanna Haapanen, Silvia Bua, Marianne Kuuslahti, Seppo Parkkila, Claudiu T Supuran

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. An anion and small molecule inhibition study of the β-carbonic anhydrase fromJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  5. Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase fromJournal of enzyme inhibition and medicinal chemistry · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Susanna HaapanenFaculty of Medicine and Health Technology, University of Tampere, 33100 Tampere, Finland. Haapanen.Susanna.E@student.uta.fi.ORCID 0000-0003-3833-6629
Silvia BuaNeurofarba Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy. silvia.bua@unifi.it.ORCID 0000-0003-0107-2682
Marianne KuuslahtiFaculty of Medicine and Health Technology, University of Tampere, 33100 Tampere, Finland. Marianne.Kuuslahti@staff.uta.fi.
Seppo ParkkilaFaculty of Medicine and Health Technology, University of Tampere, 33100 Tampere, Finland. seppo.parkkila@staff.uta.fi.ORCID 0000-0001-7323-8536
Claudiu T SupuranNeurofarba Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy. claudiu.supuran@unifi.it.ORCID 0000-0003-4262-0323
Tampere University · FIUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the cloning and catalytic activity of a β-carbonic anhydrase (CA, EC 4.2.1.1), isolated from the pathogenic protozoan

Indexed as

Carbonic AnhydrasesCloning, MolecularEntamoeba histolyticaProtozoan ProteinsCarbonic Anhydrase InhibitorsCarbonic Anhydrase InhibitorsCarbonic AnhydrasesProtozoan Proteinsanionscarbonic anhydraseEntamoeba histolyticainhibitormetalloenzymesprotozoan

Identifiers

PMID30486513
PMCPMC6321543
OpenAlexW2902816903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.